MICHAEL CHEN: Open Payments
NPI 1487711123 · SANDY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 50 payments from 10 companies in 2025. Trend: 2023 $2,459 · 2024 $1,096 · 2025 $1,053
Food & beverage: $794Speaker / faculty: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $424 |
| PFIZER INC. | 11 | $252 |
| Collegium Pharmaceutical, Inc. | 14 | $162 |
| Globus Medical, Inc. | 2 | $54 |
| Boston Scientific Corporation | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Radius Health, Inc. | 2 | $29 |
| SPR Therapeutics, Inc | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: NURTEC ODT, Belbuca, QULIPTA, ZAVZPRET, Senza, BOTOX, JOURNAVX, XTAMPZA.
Industry payments across UT — which companies pay providers there.
